Tony W. Ho;Gene C. Kopen;William F. Righter;J. Lynn Rutkowski;Joseph Wagner
发明人:
Tony W. Ho,Gene C. Kopen,William F. Righter,J. Lynn Rutkowski,Joseph Wagner
申请号：
US11797322
公开号：
US10351826B2
申请日:
2007.05.02
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell population which co-express CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and formulate pharmaceutical compositions.
